甲酸激酶M2链接新陈代谢和表观遗传学:肝脏疾病治疗的新目标
Xiaoya Zhang1, Danmei Zhang1, Jin Guo1
1Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Biomolecules
|September 27, 2025
概括
改变的葡萄糖分解和酸盐激酶M2 (PKM2) 是肝脏疾病的关键. 本综述详细介绍了PKM2的修改如何影响其功能,为肝脏疾病提供了潜在的治疗点.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 异常葡萄糖分解是肝病进展的标志.
- 酸激酶M2 (PKM2) 调节糖解和核功能,影响基因转录.
- 了解PKM2的调节机制对于治疗开发至关重要.
研究的目的:
- 审查翻译后修改对PKM2.2的影响.
- 探索PKM2在整合表观遗传学和新陈代谢中的作用.
- 为开发针对肝脏疾病的PKM2向疗法提供基础.
主要方法:
- 对PKM2.2的翻译后修改的文献综述.
- 分析PKM2的结构,活动和局部变化.
- 合成PKM2在表观遗传和代谢调节中的作用.
主要成果:
- 翻译后的修改显著改变了PKM2的特性.
- PKM2 整合了表观遗传和代谢途径.
- 突出了PKM2的核转移和辅助因子活动.
结论:
- 向PKM2为肝脏疾病提供了一个有前途的治疗策略.
- PKM2独特的生化特性使其成为一种可行的药物标.
- 对PKM2调节的进一步研究可以促进肝病治疗.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.6K
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
8.6K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Phase II Reactions: Methylation Reactions
676
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
676
